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Background: Patient-reported outcome measures (PROMs) are used by clinical quality registries to assess patients’
perspectives of care outcomes and quality of life. PROMs can be assessed through a self-administered survey or
by a third party. Use of mixed mode approaches where PROMs are completed using a single or combination of
administration method is emerging. The aim of this study is to identify the most cost-effective efficient approach
to collecting PROMs among three modes (telephone, postal service/mail and email) in a population-based clinical
quality registry monitoring survivorship after a diagnosis of prostate cancer. This is important to assist the registry in
achieving representative PROMs capture using the most cost-effective technique and in developing cost projections
for national scale-up.
Methods/design: This study will adopt an equivalence randomised controlled design. Participants are men
diagnosed with and/or treated for prostate cancer (PCa) participating in PCOR-VIC and meet the criteria for 12-month
follow-up. Participants will be individually randomized to three independent groups: telephone, mail/postal, or email
to complete the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) survey. It is estimated each group will
have 229 respondents. We will compare the proportion of completed surveys across the three groups.
The economic evaluation will be undertaken from the perspective of the data collection centre and consider all
operating costs (personnel, supplies, training, operation and maintenance). Cost data will be captured using an Activity
Based Costs method. To estimate the most cost-effective approach, we will calculate incremental cost-effectiveness
ratios. A cost projection model will be developed based on most cost-effective approach for nationwide scale-up of
the PROMs tool for follow-up of PCa patients in Australia.
(Continued on next page)* Correspondence: emdad.hoque@monash.edu
1Department of Epidemiology and Preventive Medicine (DEPM), School of
Public Health and Preventive Medicine, Monash University, The Alfred Centre,
Level 6, 99 Commercial Road, Melbourne, VIC 3004, Australia
2International Centre for Diarrhoeal Diseases Research in Bangladesh
(icddr,b), 68, Shahid Tajuddin Sarani, Mohakhali, Dhaka 1212, Bangladesh
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hoque et al. BMC Health Services Research  (2017) 17:75 Page 2 of 10(Continued from previous page)
Discussion: This study will identify the most cost-effective approach for collecting PROMs from men with PCa, and
enable estimation of costs for national implementation of the PCa PROMs survey. The findings will be of interest to
other registries embarking on PROMs data collection.
Trial registration: ACTRN12615001369516 (Registered on December 16, 2015)
Keywords: Data collection methods, Randomized Controlled Trial, Cost-effectiveness, Patient Reported Outcome
Measures, Mixed-modeBackground
Patient reported outcome measures (PROMs) are de-
signed to measure patients’ views of their symptoms,
own functional status, treatment satisfaction and health
related quality of life in relation to specific disease or
conditions [1–4]. PROMs are an important measure of
patients’ perspective of care outcomes as they provide
insight into the impact of a disease and its treatment on
daily lives. PROMs can assist clinicians to work with
patients to achieve a level of care that meets their needs;
this has been demonstrated to improve patient-provider
communication [5].
PROMs may be self-administered or administered by
another person (third-party). Instruments used to collect
PROMs should be validated for the mode with which
they are being administered. Self-administration may in-
clude surveys that patients complete on paper or elec-
tronically (e.g. via links provided in an email address to
an online form or through Applications (apps) that
patients can download. Tools administered by another
person may include those completed on paper or elec-
tronically with assistance or those administered over the
telephone [6, 7]. With the increasing number of Internet
users, greater opportunities exist for collecting data,
through mechanisms such as email and web-based sur-
veys [8, 9]. An emerging trend in health-related survey
research is the use of a mixed-mode approach. In the
mixed-mode method, individuals may respond using a
single or combination of different modes, such as only
telephone or mail followed by telephone [10]. Using a
mixed-mode approach compensates for the weaknesses
of each individual mode at affordable cost [11]. Survey
mode, length and content of the survey and incentives
will impact the response rates and the cost of data col-
lection [12].
The amount of clinical data being collected is growing
exponentially; largely due to computer-based informa-
tion systems [13]. In Australia, the number of known
registries collecting clinical data has risen from 28 in
2006-07 to 37 in 2012 [14]. Clinical quality registries
have received increasing attention as a means of improv-
ing quality and reducing the cost of health and medical
care, through identifying variations in clinical practice
and care, and assessing the uptake of effective treatment[15, 16]. A number of clinical quality registries collect
PROMs and provide reports on outcomes to hospitals.
Examples can be found in trauma [17], joint replacement
[18] and renal disease [19]. PROMs are being developed
by the American Society of Clinical Oncology to bench-
mark hospitals in relation to symptoms and functional
status following cancer treatment [20].
For any individual research study, the mode of data
collection is influenced by time, available resources and
the population being targeted [21]. A number of studies
have compared response rates using different modes of
data collection [22]. A meta-analysis published in 2009
found that email surveys have lower response rates
compared with mail surveys (20% vs 53% respectively)
suggesting that, despite rapid growth of information
technology, mail surveys appear to be superior to email
in collecting survey data [22]. High response rates have
been obtained when follow up attempts are intense and
personalised. For example Steineck et all reported very
high response rates of 89 to 99% across multiple time
periods by following a regimen which included an intro-
duction letter and a telephone call to establish contact
prior to a survey being posted and a “thank you and
reminder” card following return of the survey [23, 24]. It
is unclear whether such a labour-intensive approach is
sustainable at a population level.
Response rates have been found to vary among study
populations. Postal surveys with three reminders have
shown demonstrably better response rates among gen-
eral practitioners compared with a telephone survey
[25]. A randomised control trial (RCT) of junior medical
staff and faculty members comparing electronic and pos-
tal surveys found that response rates were similar, but
the average response time for electronic surveys was
shorter for the residents’ group compared with the
faculty group (3.8 days vs 8.4 days, p < 0.001) [26].
A recent meta-analysis by Rutherford et al. [27] inves-
tigated whether the mode of PROMs administration
introduced bias into the patient reported outcome re-
sults. Findings suggested that there was no bias associ-
ated with whether PROMs were collected electronically
(computer including web, touch screen, hand-held
device, video conference, computer assisted telephone
interview), via paper self-completion (hard copy) or via
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of the study recommended further research using ex-
perimental designs to measure the mediators of mode
effects on data quality, measurement equivalence, reli-
ability of assessment for individuals and the impact of
setting and combination of data collection method
over time [27].
A cost-effectiveness study by Sinclair et al. (2012)
found that postal survey costs were lower compared
to both internet and telephone. The cost of a com-
pleted response using a personalised postal survey
(24.75 Australian Dollars) was slightly higher than
the generic postal survey, a generic internet survey
and a personalised internet survey cost was almost
double of a personalised postal survey and a tele-
phone survey cost was highest among all methods
[28]. Another study conducted by the Australian
national stroke registry, found that telephone follow
up for patient with acute stroke or transient ische-
mic attack was more expensive but more effective in
terms of completion rates than follow-up by postal
mail [16].
The Victorian Prostate Cancer Registry (PCOR-VIC)
was established in 2009 to monitor treatment and
outcomes of men diagnosed with prostate cancer in
Victoria. PROMs are collected to assess the impact of
prostate cancer diagnosis/treatment on urinary, bowel,
hormonal, and sexual function and bother using the
EPIC-26 survey [29]. The EPIC-26 survey has been
validated for telephone and self-administered survey
(paper or online) and is currently only administered
by telephone [30]. The response rate has varied over
time as modifications have been made to the registry
and is currently at 85%. Alternative methods of
PROMs administration have not been systematically
assessed for their cost-effectiveness and feasibility.
Although previous studies demonstrated lower
response rates and in some cases increased costs of
surveys delivered electronically, these were conducted
several years ago and on a different population. As
the PCOR-VIC is now contributing to a newly devel-
oped Prostate Cancer Registry-Australia and New
Zealand, [31] the aim of this project was to assess the
most cost-effective approach for collecting PROMs in
a prostate cancer population.
The current study protocol describes the design of an
equivalence RCT to assess the cost-effectiveness of three
different methods of PROMs data collection using the
EPIC-26 survey for patients diagnosed with prostate
cancer.
The primary objective of the trial is to compare the
completeness of survey data obtained using the three
different data collection approaches for reporting on
PROMs.The secondary objectives are to:
a. Estimate recurrent costs of data collection using
telephone, postal services/mail and electronic mail
(email) for PROMs data in PCOR-VIC.
b. Compare the cost-effectiveness of the three different
methods of data collection.
c. Develop a cost projection model to estimate the cost
for nation-wide scale-up of administering the
PROMs data collection tool in the most efficient
setting for follow up of prostate cancer patients in
Australia.Methods/design
Setting
Men who are diagnosed with prostate cancer in Victoria,
contributing to the PCOR-VIC and who are interviewed
by researchers to collect PROMS, will be invited to par-
ticipate in this study. Since its establishment in 2009 the
registry has expanded to 33 hospitals across the state,
representing approximately 75% of the Victorian popula-
tion [32]. Men are eligible for inclusion on the register if
they have had a histologically confirmed diagnosis of
prostate cancer that is notified to the Victorian Cancer
Registry by the hospital.Trial design
The study design proposed for this evaluation is an
equivalence RCT design. Participants will be individu-
ally randomized to one of three independent groups
receiving the PROMs instrument by email, post or by
telephone. Due to the nature of the intervention, it is
not possible to blind the researchers or study
participants.
To collect costing data we will use an Activity Based
Costing (ABC) method [33] and structured question-
naires to estimate the cost of the operational activities of
the three different methods of follow up. The ABC
method is useful for understanding key activities of any
programs and interventions and allows identification of
(i) implementation levels and composition of costs; (ii)
variations in how an intervention is implemented over
time and associated cost implications; and (iii) resulting
costs of increasing coverage of cost-effective data collec-
tion methods. This method is flexible, so its resulting
estimates can be easily understood and adapted to meas-
ure the cost of data collection of the three different
methods. Costs that will be considered include personnel
cost, cost of supplies (e.g., envelopes, printing etc.), cost of
training of data collectors and cost of operation and main-
tenance (e.g., telephone bill, internet bill, rent etc.) for
each of the data collection methods.
Hoque et al. BMC Health Services Research  (2017) 17:75 Page 4 of 10Recruitment of patients
Recruitment of patients to the PCOR-VIC has been previ-
ously described [34]. In summary, patients diagnosed in
recruiting hospitals and notified by the hospital to the
registry are sent details of the registry in an explanatory
statement by mail. In the explanatory statement details on
what data will be collected from the patient’s medical rec-
ord and directly from the patient and how a man can opt
off the registry if he chooses not to participate are included.
The explanatory statement also contains the contact details
of both the hospital where the patient was diagnosed and
the university conducting the research and hosting the
registry. Clinical data are collected on men who do not opt
out. A waiver of consent enables clinical details to be col-
lected from men who have died after diagnosis.
Eligible men are contacted by centrally-located univer-
sity call-centre follow up staff to confirm that clinical data
are accurate and up-to-date. For data collection contact is
made any time within a window period of 21 days on ei-
ther side of the anniversary date for data collection
(henceforth recorded as the “Anniversary Date”). This is
12 months from the date of the positive biopsy for pa-
tients who do not proceed to active treatment or only re-
ceive androgen deprivation therapy; or 12 months from
the date on which final initial treatment, or course of
treatment finished. This is also the date for surgery and
low-dose rate (seed) brachytherapy procedure. For radio-
therapy and chemotherapy this is the date that the last
dose of therapy was provided as well.
Inclusion criteria
Men will be included in this study if they are eligible
and have been included on the PCOR-VIC, are aged
>18 years and answer the telephone when contacted by
data collectors in the 21 days leading up to and includ-
ing their Anniversary Date.
Exclusion criteria
Men will be ineligible for inclusion in the RCT if they
opt off the registry, have died in the period between
being recruited to the registry and telephoned, do not
speak English, are identified as being hearing or men-
tally impaired when contacted by data collectors to
administer the PROMs, have been diagnosed by
Transurethral Resection of the Prostate (TURP) and
their treating doctor has requested that we do not
contact them for follow up, or if they answer the tele-
phone after their Anniversary Date.
Outcome of interest
Primary outcome
The primary outcome of interest will be effective
successful follow up. Effective successful follow up is
defined as providing a response to each of the 26questions in the survey. Provision exists for patients to
record “decline to answer’ on the electronic form and
they are advised at the beginning of the phone call that
they may chose not to answer if they wish. Responses
will still be considered completed if the patient declines
to answer.
Secondary outcomes
Secondary outcome measures include time to complete
an effective follow-up, and the number of occasions
where answering a question was declined for each mode
of survey administration.
Sample size
Sample size calculations were based on an equivalence
study design [35] and the primary outcome measure
(completeness of survey responses). Given the current
follow up response rates from the PCOR-VIC we esti-
mate that we will achieve a response rate of 90% [32]
when PROMs are administered by the telephone follow-
up method. The study was designed to evaluate whether
the completeness of survey responses in the ‘mail/postal
service group’ or ‘email group’ was similar to the ‘tele-
phone’ group. Assuming that the equivalence margin is
10%, we will require 190 respondents per group. We
have made an assumption that the 83% of who have
internet access will also have an email account [36]. The
sample size was adjusted accordingly so the final num-
ber of respondents required in each group is 229 giving
a total number required n = 687 (Table 1). Our sample
size has been calculated to provide a level of significance
at 5% with 80% power (2-sided test). The sample size
calculation was performed in Stata V13.0 [37].
Randomisation process
Figure 1 illustrates the different steps for following up
patients on the PCOR-VIC registry to complete the
PROM (EPIC-26 survey). The first step after data collec-
tors’ telephone to men is to confirm treatment and GP
details and obtain the most recent PSA result. If the
patient is contacted within the window from 21 days
before the “Anniversary Date”, then they will be eligible
for randomization. Randomization will be undertaken
using random permuted blocks of sizes 3 and 6 [38].
The investigator will have already generated the random
blocks and provide those to the data collectors in sealed
envelopes. Once the data collector has confirmed the
patient’s PSA result, GP details and eligibility for
12-month follow-up then s/he will proceed with select-
ing a random number from the sealed envelope to as-
sign the method for collection of data by EPIC-26
survey. If a patient has been assigned to the email
method but, when the data collector asks for an email
address and the patient replies that he does not have











Response rate 90% 10% 190 83% 229 687
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quent envelopes until either the telephone method
(Intervention A) or mail/postal methods (Intervention B)
is assigned.
Description of intervention(s)/exposure
An attempt will be made to contact all men who have
not opted off the registry and meet the eligibility criteria.
The details and procedure followed by data collectors
for administering the EPIC-26 survey following random-
isation to one of the three approaches is described below
and presented in Fig. 1 Flow Chart showing 3 different
follow up methods.
Intervention A: PROMs data collection by follow-up
data collectors over the telephone
1. An attempt to contact patients via phone will be made up
until 21 days post diagnosis/treatment. Each day a data
collector will make one attempt to contact the patient.
2. Patients responding will have PROMS entered
directly to the PCOR-VIC web system.
3. Patients will be considered lost to follow up if they
do not respond after 21 days from 12 month
“Anniversary Date”.
Intervention B: Data collection by follow up data col-
lectors by mail (postal service)
1. The EPIC-26 survey will be mailed to patients if
they are contacted any time from 21 days before,
up to and including the “Anniversary Date”. The
survey will be accompanied with a personalised,
signed letter with instructions and a postage-paid,
self-addressed envelope.
2. If the survey is not returned by 14 days
post the Anniversary Date, patients will be
telephoned as per Intervention A. Data
collector will make one attempt each day
i.e 14 attempts in total.
3. Patients will be considered lost to follow up if they
do not respond after 21 days from 12 month
“Anniversary Date”.
Intervention C: Data collection by E-mail link to
online survey
1. If email is not available then the participants will be
randomly assigned to either telephone (intervention
A) or mail (Intervention B).2. A Uniform Resource Locator (URL) which is the
address of a web page link to the EPIC-26 survey
will be emailed to participants if they are contacted
any time from 21 days before, up to and including
the “Anniversary Date”.
3. If participants do not complete the online survey by
14 days post the Anniversary Date, patients will be
telephoned as per Intervention A. Data collector will
make one attempt each day i.e 14 attempts in total.
Patients will be considered lost to follow-up if they
do not respond after 21 days from 12 month “Anni-
versary Date”.
Duration of the project
We anticipate that the recruitment process will com-
mence on the 1stof February 2016. Data collection will
take place between February 2016 and November 2016.
Based on current number of patients that become eli-
gible for follow-up each month, we anticipated that it
will require approximately 8-9 months to reach our total
sample size of 687. An additional 2 months will be
required for entering, analysing costing data and for
report writing and developing draft manuscripts.
Data collection, quality and monitoring methods
We will employ quantitative methods of data collection
through structured questionnaires. For costing, the ABC
[33] method will be adopted. Table 2 describes the data
collection methods that will be used to obtain data for
each specific objectives. Data will be collected by trained
data collectors and supervised by the project manager
and study investigators. Data collectors are from an
academic institution (Monash University) and are inde-
pendent of the hospitals. To ensure data quality, valid-
ation tools will be built in the web-based system.
Routine monitoring meeting will also be held to ensure
any problems encountered during data collection and
randomization process.
Data analysis plan
Primary and secondary outcomes
For the primary outcome measure (completeness of sur-
veys), we will estimate individual proportions with 95%
CI for each arm of the trial. We will then calculate the
pooled sample proportions for each pair and the stand-
ard error of the difference. Using these measures, we will
calculate the Z score test statistics. The p value will be
reported for the difference and P < 0.05 will be consid-
ered as statistically significant.
Fig. 1 Flow chart showing 3 different follow-up methods
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out independent sample t-tests to detect the difference.
Analysis will be conducted by intention to treat (ITT)
[39] as well as per protocol method [40]. The ITT method
will allow us to evaluate the effect of each intervention in
a real life situation (i.e. when subjects are randomized to
the ‘email group’ but end up in the ‘telephone’ or ‘mail’
methods instead). The per-protocol method will allow us
to study the direct effect of each option.
Economic analysis
The economic evaluation will consider the costs of
personnel resources, supplies, and operating costs as de-
scribed below. The analysis will not consider developmentof the PCOR-VIC database, as we consider that this cost
will be identical regardless of the data collection modality.
However, the additional costs associated with developing
the automated email system within the register will be
captured.
a. Valuing personnel resources
The value of the research staff contacting patients
will be measured in terms of salaries, allowances and
benefits received during the study period for their
time. At Monash University, all personnel maintain
a time sheet for their usual activities. We shall
calculate time taken for the data collection processes















Table 2 Description of the specific objectives and methods
Objectives Methods
1 To compare the completeness of data across the three data
collection approaches.
Total number of completed surveys will be identified in and compared
across each of the three PROMS data collection approaches. Both the
paper and electronic version provide capacity for patients to decline to
answer any question. Provision in the electronic survey exists to alert
patients where fields are left blank to prevent missing data issues.
2 To measure the cost of data collection of three different methods:
Telephone, Mail (Postal services) and Email for Patient Reported
Outcome Measures (PROMs) data in PROC-Vic.
The Activity Based Costing (ABC) method will be followed to estimate
the cost of the operational activities of the three different methods of
follow up.
The costing data will be collected from provider perspective. Table 3:
Describes the itemized costs of the 3 different methods.
3 To compare the cost and effectiveness of three different methods
of data collection
Cost-effectiveness: Total cost (Personnel, recurrent, supply—)/Number
of completed follow-up patients
4 To develop a model to determine the cost for national scale-up of
PROMs data collection method with EPIC-26 survey in Australia.
A cost projection model will be developed based on most efficient
approach. The model will use epidemiological data and estimated cost
parameters. Estimated incidence data on national prostate cancer cases
and completed follow up of patients will be forecasted. Using estimated
cost data will help to determine the cost for national scale-up of follow
up per year.
A sensitivity analysis will be conducted with different assumptions e.g. (1)
total number of prostate cancer patients; (2) completed follow up surveys
and; (3) cost.
5 To provide recommendations for most cost-effective approach for
complete follow-up of prostate cancer patient
A comprehensive report with recommendations will be developed.
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competence required to undertake all tasks are
comparable, we will cost the time using a consistent
salary across all three groups.
b. Valuing supplies and other recurrent costs
The values of line items outlined in Table 3 will
be included as variable inputs and valued at the
price at which they were obtained. Items obtained
free of cost will be valued at market price –
that is, the price paid if purchased from the
local or international market. If price from the
international market is used then that price
will be changed in Australian dollars using the
purchasing power parity (PPP) of Australian dollar
with USD in 2015 [41]. The actual expenditure
for rent, utilities and supervision during the yearble 3 Cost data collection of 3 different methods
Telephone
rsonnel time cost (Time to contact and
mplete patient surveys, as well as
ministrative tasks such as filing forms,
ta entry, and checking patient data)
Spread sheet to keep the time
of the data collection staff
aining cost (Time cost of the trainers
d trainee, food costs if any and training
aterials costs)
Yes




lephone costs – all receive initial phone
ll, plus telephone costs for collection via
e telephone.
Yeswill be taken into account [41]. These costs data will
be collected from the managers of the data collection
facilities using a structured questionnaire.
c. Methodology of time allocation of providers
Data collectors will maintain a spreadsheet to record
the time spent for each data collection method. The
time will be categorised into direct data collection and
non-service professional activities which includes
preparatory activities, maintaining and management
of records and information, and obtaining supplies.
d. Calculating Total and Average Costs:
We will sum personnel costs, cost of supplies,
training costs and costs of operation and
maintenance to provide a total cost for each of the
follow up methods as well as average cost for each
constituent items.Mail (Postal service) E-mail
Spread sheet to keep the time
of the data collection staff
Spread sheet to keep the time





Hoque et al. BMC Health Services Research  (2017) 17:75 Page 8 of 10e. Estimating cost effectiveness
To estimate the most cost-effective approach,
incremental cost effectiveness ratios (ICERs) will
be estimated. This involves comparing the incremental/
additional cost of one approach with the additional
outcome achieved by using that approach. Outcome
will be measured as completed surveys. The most cost
effective approach will be the method which achieves
the greatest percentage of complete surveys at the least
cost [42]. Scenario analysis will be undertaken to test
some of the assumptions in estimating the cost of each
approach.
Cost projection modelling
A cost projection model will be developed based on the
most cost-effective approach for collecting completed
PROMs surveys. The model will use epidemiological
data (Australian prostate cancer incidence data) and the
estimated follow-up cost. A sensitivity analysis will be
conducted using different follow up rates and cost
assumptions.
Quality assurance
This study will be conducted in accordance with the
National Health and Medical Research Council
(NHMRC) Code of Responsible Conduct of Research.
Dissemination of results and publication policy
Results of this study will be disseminated to the scientific
community through conferences, seminars presentations
and publications in peer-reviewed journals. We will
present the findings at the Registry Special Interest
Group at Monash University to ensure that the lessons
learned in the PCOR-VIC registry are made available to
other registry custodians.
Data storage, access and security arrangements
The PCOR-VIC data are housed on a secure server at
Monash University. Security is maintained using encryp-
tion of data, a managed and audited protocol for access,
training and accreditation of personnel, role-based ac-
cess and authentication of data. The database storing
PROMs and costing data will be password protected and
stored on a networked server that is backed up on a
daily basis at Monash University.
Potential risks
As the participants are diagnosed with prostate cancer,
they may experience distress when discussing the disease
with follow up staff over telephone. There will be no
pressure on the participants to divulge any information
if they do not feel comfortable to do so. An offer will be
made to terminate the interview if the participants
exhibit any signs of distress. The interview will onlybe continued if the participants want to do so. As
there will be no physical examination, biomedical
tests (invasive/non-invasive) or use of hazardous ma-
terial, this project is deemed to be a low-risk research
activity.Discussion
Through this economic analysis we will determine the
most cost-effective means of capturing PROMs and
completing follow up of prostate cancer patients through
the PCOR-VIC using the EPIC-26 survey. Our primary
aim therefore is to identify the value of different PROMS
collection methods. Value is defined as outcomes relative
to costs and encompasses efficiency [43]. The outcome
we will be evaluating is response rates and represen-
tativeness of the various tools in assessing the quality
of life. With knowledge of the cost of each completed
survey, we will decide which approach to use as we
expand data collection to obtain national coverage.
Our primary objective is to assess the response rate
across each data collection approach. Surveys will
only be considered as completed if all relevant ques-
tions have been answered.
This will provide guidance to other registries under-
taking follow up surveys of patients and it will also allow
us to estimate the cost for collecting PROMs data within
the Prostate Cancer Outcome Registry- Australia. More-
over we will be able to understand the quality of PROMs
data collected by the three different methods. It may be
that one method produces significantly higher rate of
missing data or questions which patients decline to an-
swer. We have to weigh the cost of data collection
against completeness of surveys to determine the
method which provides the greatest value at the end of
the study. This decision will be made by the project
steering committee and the funder.Conclusion
The aim of this study is to provide evidence on which
method of PROMs follow up data collection is more
cost-effective. Findings of this study will also help us in
understanding the cost for national implementation of
the prostate cancer quality of life questionnaire in
Australia.
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